BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Onyx Pharmaceuticals, Inc. (ONXX) Doubles On Positive Nexavar News


2/12/2007 2:06:27 PM

February 12, 2007 -- Onyx and Bayer announced positive results for cancer drug Nexavar (sorafenib) in patients with liver cancer. The drug was so successful that the Phase III trial was stopped early, on the advice of the data safety monitoring committee, and Nexavar was given to all participants. Specific data were not released, but the full results are expected at ASCO in June. Nexavar was approved in late 2005 for kidney cancer, and it has solid, though not spectacular sales. The news had a very positive effect on the shares of Onyx, which rose over 90%. We look at a history of the drug and its maker, Onyx...


   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES